Creatine and Creatinine Metabolism - Physiological Reviews

1198 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
551. LEMPERT C. The chemistry of the glycocyamidines. Chem Rev 59:
667–736, 1959.
552. LEVI M, BAIRD BM, AND WILSON PV. Cholesterol modulates rat
renal brush border membrane phosphate transport. J Clin Invest
85: 231–237, 1990.
553. LEVILLAIN O, HUS-CITHAREL A, MOREL F, AND BANKIR L.
Arginine synthesis along the mammalian nephron. In: Guanidino
Compounds in Biology and Medicine, edited by P. P. De Deyn, B.
Marescau, V. Stalon, and I. A. Qureshi. London: Libbey, 1992, p.
63–70.
554. LEVILLAIN O, MARESCAU B, AND DE DEYN PP. Guanidino compound
metabolism in rats subjected to 20% to 90% nephrectomy.
Kidney Int 47: 464–472, 1995.
555. LEVILLAIN O, MARESCAU B, AND DE DEYN PP. Renal handling
of guanidino compounds in rat and rabbit. J Physiol (Lond) 499:
561–570, 1997.
556. LEVINE S, TIKUNOV B, HENSON D, LAMANCA J, AND SWEENEY
HL. Creatine depletion elicits structural, biochemical, and physiological
adaptations in rat costal diaphragm. Am J Physiol Cell
Physiol 271: C1480–C1486, 1996.
557. LEWIS W AND DALAKAS MC. Mitochondrial toxicity of antiviral
drugs. Nature Med 1: 417–422, 1995.
558. LIAO R, NASCIMBEN L, FRIEDRICH J, GWATHMEY JK, AND
INGWALL JS. Decreased energy reserve in an animal model of
dilated cardiomyopathy. Relationship to contractile performance.
Circ Res 78: 893–902, 1996.
559. LILLIE JW, O’KEEFE M, VALINSKI H, HAMLIN HA, VARBAN ML,
AND KADDURAH-DAOUK R. Cyclocreatine (1-carboxymethyl-2iminoimidazolidine)
inhibits growth of a broad spectrum of cancer
cells derived from solid tumors. Cancer Res 53: 3172–3178,
1993.
560. LILLIE JW, SMEE DF, HUFFMAN JH, HANSEN LJ, SIDWELL RW,
AND KADDURAH-DAOUK R. Cyclocreatine (1-carboxymethyl-2iminoimidazolidine)
inhibits the replication of human herpes viruses.
Antiviral Res 23: 203–218, 1994.
561. LIN D, MEYER DJ, KETTERER B, LANG NP, AND KADLUBAR FF.
Effects of human and rat glutathione S-transferases on the covalent
DNA binding of the N-acetoxy derivatives of heterocyclic
amine carcinogens in vitro: a possible mechanism of organ specificity
in their carcinogenesis. Cancer Res 54: 4920–4926, 1994.
562. LIOTTA LA AND STRACKE ML. Tumor invasion and metastasis:
biochemical mechanisms. In: Breast Cancer: Cellular and Molecular
Biology, edited by M. Lippman and R. Dickson. Boston, MA:
Kluwer, 1988, p. 223–238.
563. LIPTON P AND WHITTINGHAM TS. Reduced ATP concentration
as a basis for synaptic transmission failure during hypoxia in the
in vitro guinea-pig hippocampus. J Physiol (Lond) 325: 51–65,
1982.
564. LIRON Z, WONG E, AND ROBERTS E. Studies on uptake of �-aminobutyric
acid by mouse brain particles: toward the development
of a model. Brain Res 444: 119–132, 1988.
565. LIU Q-R, LÓPEZ-CORCUERA B, MANDIYAN S, NELSON H, AND
NELSON N. Molecular characterization of four pharmacologically
distinct �-aminobutyric acid transporters in mouse brain. J Biol
Chem 268: 2106–2112, 1993.
566. LLORETA J, OROZCO M, GEA J, COROMINAS JM, AND SERRANO
S. Selective diaphragmatic mitochondrial abnormalities in a patient
with marked air flow obstruction. Ultrastruct Pathol 20:
67–71, 1996.
567. LLORETA J, ROQUER J, COROMINAS JM, AND SERRANO S.
Hyperthyroid myopathy with mitochondrial paracrystalline rectangular
inclusions. Ultrastruct Pathol 20: 61–65, 1996.
568. LOIKE JD, CAO L, BRETT J, OGAWA S, SILVERSTEIN SC, AND
STERN D. Hypoxia induces glucose transporter expression in
endothelial cells. Am J Physiol Cell Physiol 263: C326–C333, 1992.
569. LOIKE JD, KOZLER VF, AND SILVERSTEIN SC. Creatine kinase
expression and creatine phosphate accumulation are developmentally
regulated during differentiation of mouse and human
monocytes. J Exp Med 159: 746–757, 1984.
570. LOIKE JD, SOMES M, AND SILVERSTEIN SC. Creatine uptake,
metabolism, and efflux in human monocytes and macrophages.
Am J Physiol Cell Physiol 251: C128–C135, 1986.
571. LOIKE JD, ZALUTSKY DL, KABACK E, MIRANDA AF, AND SIL-
VERSTEIN SC. Extracellular creatine regulates creatine transport
in rat and human muscle cells. Proc Natl Acad Sci USA 85:
807–811, 1988.
572. LOO G, GOODMAN PJ, HILL KA, AND SMITH JT. Creatine metabolism
in the pyridoxine-deficient rat. J Nutr 116: 2403–2408, 1986.
573. LÓPEZ-VILLEGAS D, KIMURA H, TUNLAYADECHANONT S, AND
LENKINSKI RE. High spatial resolution MRI and proton MRS of
human frontal cortex. NMR Biomed 9: 297–304, 1996.
574. LOPRESTI P AND COHN M. Direct determination of creatine kinase
equilibrium constants with creatine or cyclocreatine as substrate.
Biochim Biophys Acta 998: 317–320, 1989.
575. LORTET S, HECKMANN M, AUSSEDAT J, RAY A, VINCENT M,
SASSARD J, ZIMMER H-G, AND ROSSI A. Alteration of cardiac
energy state during development of hypertension in rats of the
Lyon strain: a 31 P-NMR study on the isolated rat heart. Acta
Physiol Scand 149: 311–321, 1993.
576. LORTET S, HECKMANN M, RAY A, ROSSI A, AUSSEDAT J,
GRABLY S, AND ZIMMER H-G. Energy metabolism response to
calcium activation in isolated rat hearts during development and
regression of T 3-induced hypertrophy. Mol Cell Biochem 151: 99–
106, 1995.
577. LOWE JA, MURPHY M, AND NASH V. Changes in plasma and
muscle creatine concentration after increases in supplementary
dietary creatine in dogs. J Nutr 128: 2691S–2693S, 1998.
578. LUBEC B, AUFRICHT C, HERKNER K, HOEGER H, ADAMIKER
D, GIALAMAS H, FANG-KIRCHER S, AND LUBEC G. Creatine
reduces collagen accumulation in the kidneys of diabetic db/db
mice. Nephron 67: 214–217, 1994.
579. LUHMANN HJ AND HEINEMANN U. Hypoxia-induced functional
alterations in adult rat neocortex. J Neurophysiol 67: 798–811,
1992.
580. LUTOSLAWSKA G AND BAER HP. Creatine phosphate inhibition
of heart 5�-nucleotidase appears due to contaminants. Experientia
39: 1358–1359, 1983.
581. MACALLISTER RJ, WHITLEY GSJ, AND VALLANCE P. Effects of
guanidino and uremic compounds on nitric oxide pathways. Kidney
Int 45: 737–742, 1994.
582. MADARAS MB AND BUCK RP. Miniaturized biosensors employing
electropolymerized permselective films and their use for creatinine
assays in human serum. Anal Chem 68: 3832–3839, 1996.
583. MAGANARIS CN AND MAUGHAN RJ. Creatine supplementation
enhances maximum voluntary isometric force and endurance capacity
in resistance trained men. Acta Physiol Scand 163: 279–
287, 1998.
584. MAHANNA DA, FITCH CD, AND FISCHER VW. Effects of �-guanidinopropionic
acid on murine skeletal muscle. Exp Neurol 68:
114–121, 1980.
585. MAHLER M. Control of oxygen consumption in normal and dystrophic
skeletal muscle. In: Heart Creatine Kinase, edited by
W. E. Jacobus and J. S. Ingwall. Baltimore, MD: Williams &
Wilkins, 1980, p. 92–108.
586. MAIER M, RON MA, BARKER GJ, AND TOFTS PS. Proton magnetic
resonance spectroscopy: an in vivo method of estimating
hippocampal neuronal depletion in schizophrenia. Psychol Med
25: 1201–1209, 1995.
587. MAKINO H, ISHIZAKA Y, TSUJIMOTO A, NAKAMURA T, ONDA
M, SUGIMURA T, AND NAGAO M. Rat p53 gene mutations in
primary Zimbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline,
a food mutagen. Proc Natl Acad Sci USA 89:
4850–4854, 1992.
588. MAKINO H, USHIJIMA T, KAKIUCHI H, ONDA M, ITO N, SUG-
IMURA T, AND NAGAO M. Absence of p53 mutations in rat colon
tumors induced by 2-amino-6-methyldipyrido[1,2-a:3�,2�-d]imidazole,
2-amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1methyl-6-phenylimidazo[4,5-b]pyridine.
Jpn J Cancer Res 85: 510–
514, 1994.
589. MALAVEILLE C, HAUTEFEUILLE A, PIGNATELLI B, TALASKA
G, VINEIS P, AND BARTSCH H. Dietary phenolics as anti-mutagens
and inhibitors of tobacco-related DNA adduction in the urothelium
of smokers. Carcinogenesis 17: 2193–2200, 1996.
590. MALFATTI MA, BUONARATI MH, TURTELTAUB KW, SHEN NH,
AND FELTON JS. The role of sulfation and/or acetylation in the
metabolism of the cooked-food mutagen 2-amino-1-methyl-6-phe-